HomeONC • TSE
add
Oncolytics Biotech Inc
Nakaraang pagsara
$0.98
Sakop ng araw
$1.02 - $1.10
Sakop ng taon
$0.45 - $2.08
Market cap
92.38M CAD
Average na Volume
208.40K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 7.00M | -19.79% |
Net na kita | -6.69M | 3.00% |
Net profit margin | — | — |
Kita sa bawat share | -0.08 | 11.11% |
EBITDA | -6.97M | 19.83% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 15.30M | -48.31% |
Kabuuang asset | 19.70M | -43.30% |
Kabuuang sagutin | 13.21M | 12.11% |
Kabuuang equity | 6.49M | — |
Natitirang share | 88.82M | — |
Presyo para makapag-book | 12.25 | — |
Return on assets | -87.73% | — |
Return on capital | -240.66% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.69M | 3.00% |
Cash mula sa mga operasyon | -6.50M | 13.00% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 5.89M | 293.98% |
Net change in cash | -639.00K | 87.96% |
Malayang cash flow | -4.25M | 22.67% |
Tungkol
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
28
